Proto Labs Inc: Form 10-Q for the period ended Sep 30, 2018
Filed with the SEC on Oct 30, 2018 and accepted by EDGAR at Oct 30, 2018, 10:44 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-07-01 to 2018-09-30 | $115.4m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 9 months2018-01-01 to 2018-09-30 | $332.8m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2018-07-01 to 2018-09-30 | $53.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2018-01-01 to 2018-09-30 | $153.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2018-07-01 to 2018-09-30 | $62.4m | us-gaap:GrossProfit |
| Gross profit | 9 months2018-01-01 to 2018-09-30 | $179.5m | us-gaap:GrossProfit |
| Research and development | 3 months2018-07-01 to 2018-09-30 | $7.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2018-01-01 to 2018-09-30 | $21.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2018-07-01 to 2018-09-30 | $25.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2018-01-01 to 2018-09-30 | $68.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2018-07-01 to 2018-09-30 | $4.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2018-01-01 to 2018-09-30 | $12.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-07-01 to 2018-09-30 | $20.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months2018-01-01 to 2018-09-30 | $57.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-07-01 to 2018-09-30 | $0.77 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2018-01-01 to 2018-09-30 | $2.10 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-07-01 to 2018-09-30 | $0.77 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2018-01-01 to 2018-09-30 | $2.13 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2018-07-01 to 2018-09-30 | 27,337,886 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2018-01-01 to 2018-09-30 | 27,268,311 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2018-01-01 to 2018-09-30 | $85.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2018-01-01 to 2018-09-30 | $61.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2018-09-30 | $62.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-09-30 | $200.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-09-30 | $595.9m | us-gaap:Assets |
| Current liabilities | At period end2018-09-30 | $49.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-09-30 | $64.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-09-30 | $531.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-18-019017. Last ingested by Listed: Nov 4, 2026, 18:20 ET. Listed shows no prices and gives no investment advice.